Saturday, July 11, 2026

Drug profile · INN

fosmanogepix

fosmanogepix is a gpi-anchored wall transfer protein 1 inhibitor.

NMPA: clinical trials
Patents linked 16
Pipeline programs 2
News articles 0
Drug details — fosmanogepix
Class
Route
Patents
16
Programs
2
Data quality
0.70

Quick answer

fosmanogepix is a gpi-anchored wall transfer protein 1 inhibitor.

Key facts

INN fosmanogepix
Mechanism GPI-anchored wall transfer protein 1 inhibitor
Target GPI-anchored wall transfer protein 1

Mechanism of action

GPI-anchored wall transfer protein 1 inhibitor

Primary target: GPI-anchored wall transfer protein 1

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. FMGX-CS-302 Phase 3 · Anaxis Pharma · Invasive mold infections caused by Aspergillus spp., Fusariu
  2. Oral Fosmanogepix Phase 1 · Basilea Pharmaceutica · Healthy

Related patents

  1. WO 2025114603

    COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES

    Expires Wed May 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. CA 3268414

    MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS

    Expires Wed Apr 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. AR 127448

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Jan 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. WO 2023054310

    ENSEMBLE DE PERFUSION GOUTTE-À-GOUTTE INTRAVEINEUX POURVU D'UN FILTRE DE PERFUSION À ÉVENT D'AIR

    Expires Wed Apr 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. AR 123726

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA Y TIENO[3,2-H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Dec 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. TW 202214258

    Compounds and methods for treating fungal infections

    Expires Fri Apr 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. WO 2022074143

    DÉRIVÉS DE BENZO[H]QUINAZOLIN-4-AMINE ET DE THIÉNO[3,2-H]QUINAZOLIN-4-AMINE POUR LE TRAITEMENT DU CANCER

    Expires Wed Apr 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. WO 2022053708

    COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES POUR LE TRAITEMENT D'UN ADÉNOCARCINOME GASTRIQUE

    Expires Wed Mar 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. AR 119500

    DERIVADOS DE 1,2,4-OXADIAZOL-5-ONA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Dec 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. AU 2019328599

    Compounds and methods for treating fungal infections

    Expires Wed Apr 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. WO 2021048135

    COMBINAISONS PHARMACEUTIQUES COMPRENANT UN FURAZANOBENZIMIDAZOLE ET UN AGONISTE DE CD40 POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES

    Expires Wed Mar 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. CA 3147876

    DERIVES DE LA 1,2,4-OXADIAZOL-5-ONE POUR LE TRAITEMENT DU CANCER

    Expires Wed Jan 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. AR 113437

    INHIBIDORES MITOCONDRIALES PARA EL TRATAMIENTO DE TRASTORNOS DE PROLIFERACIÓN

    Expires Tue May 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. WO 2020058405

    ASSOCIATIONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DU CANCER

    Expires Wed Mar 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. CA 3103888

    PROCEDE DE PURIFICATION DE SULFATE D'ISAVUCONAZONIUM

    Expires Wed Feb 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. WO 2019115709

    INHIBITEURS MITOCHONDRIALES POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS

    Expires Wed Jun 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is fosmanogepix?

fosmanogepix is a gpi-anchored wall transfer protein 1 inhibitor.